214 related articles for article (PubMed ID: 27389397)
1. A case report of malignant hypertension in a young woman.
Michelli A; Bernardi S; Grillo A; Panizon E; Rovina M; Bardelli M; Carretta R; Fabris B
BMC Nephrol; 2016 Jul; 17(1):65. PubMed ID: 27389397
[TBL] [Abstract][Full Text] [Related]
2. [Acute renal failure associated with malignant hypertension].
Gassanov N; Pollok M; Er F
Dtsch Med Wochenschr; 2009 Oct; 134(44):2224-7. PubMed ID: 19847731
[TBL] [Abstract][Full Text] [Related]
3. Malignant hypertension: new aspects of an old clinical entity.
Januszewicz A; Guzik T; Prejbisz A; Mikołajczyk T; Osmenda G; Januszewicz W
Pol Arch Med Wewn; 2016; 126(1-2):86-93. PubMed ID: 26658350
[TBL] [Abstract][Full Text] [Related]
4. Acute renal failure induced by angiotensin converting enzyme inhibitor in a patient with polyarteritis nodosa.
Wang AY; Lai KN; Li PK; Leung CB; Lui SF
Ren Fail; 1996 Mar; 18(2):293-8. PubMed ID: 8723367
[TBL] [Abstract][Full Text] [Related]
5. [The value of renin determination in the diagnosis of hypertension].
Beckerhoff R; Siegenthaler W
Schweiz Med Wochenschr; 1976 Apr; 106(14):474-7. PubMed ID: 4881
[TBL] [Abstract][Full Text] [Related]
6. Renal hemosiderosis with uncontrolled hypertension.
Kim CS; Kim SS; Kim SW
Clin Exp Nephrol; 2018 Oct; 22(5):1224-1225. PubMed ID: 29470742
[No Abstract] [Full Text] [Related]
7. Malignant hypertension: recovery of renal function after treatment with antihypertensive medications and hemodialysis.
Adelman RD; Russo J
J Pediatr; 1981 May; 98(5):766-8. PubMed ID: 7229756
[No Abstract] [Full Text] [Related]
8. Normokalemic hyperaldosteronism in patients with resistant hypertension.
Benchetrit S; Bernheim J; Podjarny E
Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
[TBL] [Abstract][Full Text] [Related]
9. [Malignant hypertension. Significance of hypovolemia in pathogenesis and therapy of malignant hypertension].
Orth H; Möhring J; Ritz E
Dtsch Med Wochenschr; 1976 Nov; 101(45):1655-9. PubMed ID: 791604
[No Abstract] [Full Text] [Related]
10. Clinical and pathological evaluation of hypertensive emergency-related nephropathy.
Nonaka K; Ubara Y; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Hoshino J; Sawa N; Takaichi K; Kuroda Y; Oohashi K
Intern Med; 2013; 52(1):45-53. PubMed ID: 23291673
[TBL] [Abstract][Full Text] [Related]
11. Bilateral nephrectomy for malignant hypertension.
Mahony JF; Gibson GR; Sheil AG; Storey BG; Stokes GS; Stewart JH
Lancet; 1972 May; 1(7759):1036-8. PubMed ID: 4112182
[No Abstract] [Full Text] [Related]
12. Severe visual loss caused by unrecognized malignant hypertension in a 15-year-old girl.
Cortina G; Hofer J; Giner T; Jungraithmayr T
Pediatr Int; 2015 Apr; 57(2):e42-4. PubMed ID: 25868960
[TBL] [Abstract][Full Text] [Related]
13. [Successful percutaneous angioplasty of renal artery in a patient with severe arterial hypertension and symptoms of hyperaldosteronism: a case report].
Skrzypiec-Spring M; Spring A; Poczatek K; Nowicki P; Derkacz A; Ciesielska A; Negrusz-Kawecka M; Mazurek W
Kardiol Pol; 2006 Jul; 64(7):724-6; discussion 726-7. PubMed ID: 16886129
[TBL] [Abstract][Full Text] [Related]
14. Malignant hypertension with reversible brainstem hypertensive encephalopathy and thrombotic microangiopathy.
Deguchi I; Uchino A; Suzuki H; Tanahashi N
J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):915.e17-20. PubMed ID: 22418002
[TBL] [Abstract][Full Text] [Related]
15. [A case of hyperaldosteronism in childhood].
Cserháti E; Körner A
Orv Hetil; 1980 Jun; 121(24):1453-5. PubMed ID: 6108546
[No Abstract] [Full Text] [Related]
16. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
van den Born BJ; Koopmans RP; van Montfrans GA
Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
[TBL] [Abstract][Full Text] [Related]
17. Recovery from renal failure in malignant hypertension associated with primary aldosteronism: effect of an ACE inhibitor.
Suzuki H; Asano K; Eiro M; Kuriki M; Hashimoto S; Katoh T; Watanabe T; Watanabe K
QJM; 2002 Feb; 95(2):128-30. PubMed ID: 11861963
[No Abstract] [Full Text] [Related]
18. Malignant hypertension: diagnosis, treatment and prognosis with experience from the Bordeaux cohort.
Rubin S; Cremer A; Boulestreau R; Rigothier C; Kuntz S; Gosse P
J Hypertens; 2019 Feb; 37(2):316-324. PubMed ID: 30160657
[TBL] [Abstract][Full Text] [Related]
19. Discontinuation of chronic haemodialysis after control of arterial hypertension; long term follow-up.
Wauters JP; Brunner HR
Proc Eur Dial Transplant Assoc; 1983; 19():182-7. PubMed ID: 6878232
[TBL] [Abstract][Full Text] [Related]
20. Malignant hypertension. Recovery of kidney function after renal allograft failure.
Dichoso CC; Minuth AN; Eknoyan G
Arch Intern Med; 1975 Feb; 135(2):300-3. PubMed ID: 1096841
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
